{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:44:30Z","timestamp":1788871470867,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["CA94233"],"award-info":[{"award-number":["CA94233"]}]},{"name":"NIH","award":["HL091365"],"award-info":[{"award-number":["HL091365"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.yexcr.2014.05.016","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T11:00:42Z","timestamp":1401361242000},"page":"78-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment"],"prefix":"10.1016","volume":"327","author":[{"given":"Alok R.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Peirce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Durden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2014.05.016_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1084\/jem.192.1.23","article-title":"The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells","volume":"192","author":"Ogata","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.05.016_bib2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2002-11-3573","article-title":"CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes","volume":"102","author":"Yazawa","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.05.016_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature04267","article-title":"Control of B-cell responses by toll-like receptors","volume":"438","author":"Pasare","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.05.016_bib4","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1084\/jem.20061041","article-title":"Regulation of B1 cell migration by signals through Toll-like receptors","volume":"203","author":"Ha","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.05.016_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2014.05.016_bib6","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","article-title":"NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1","volume":"19","author":"Guttridge","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib7","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1073\/pnas.87.12.4727","article-title":"Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter","volume":"87","author":"Duyao","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2014.05.016_bib8","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.4049\/jimmunol.1301623","article-title":"TLR4 signaling shapes B cell dynamics via MyD88-dependent pathways and Rac GTPases","volume":"191","author":"Barrio","year":"2013","journal-title":"J. Immunol"},{"key":"10.1016\/j.yexcr.2014.05.016_bib9","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20091982","article-title":"TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones","volume":"206","author":"Hwang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.05.016_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81663-3","article-title":"Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2014.05.016_bib11","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.05.016_bib12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.imbio.2008.07.028","article-title":"Recent advances in the genetic analysis of PTEN and PI3K innate immune properties","volume":"213","author":"Gunzl","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.yexcr.2014.05.016_bib13","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.1068094","article-title":"Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt\/PKB","volume":"295","author":"Stocker","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.05.016_bib14","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1128\/IAI.71.8.4414-4420.2003","article-title":"Phosphoinositide 3 kinase mediates toll-like receptor 4-induced activation of NF-kappa B in endothelial cells","volume":"71","author":"Li","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.yexcr.2014.05.016_bib15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1189\/jlb.1208763","article-title":"TLR4\/MyD88\/PI3K interactions regulate TLR4 signaling","volume":"85","author":"Laird","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/eji.200323376","article-title":"Phosphatidylinositol 3-kinase is involved in toll-like receptor 4-mediated cytokine expression in mouse macrophages","volume":"33","author":"Ojaniemi","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"Suppl 3","key":"10.1016\/j.yexcr.2014.05.016_bib17","first-page":"iii6-12","article-title":"Differential roles of toll-like receptors in the elicitation of proinflammatory responses by macrophages","volume":"60","author":"Jones","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.yexcr.2014.05.016_bib18","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1086\/374749","article-title":"Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling","volume":"187","author":"Akira","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.yexcr.2014.05.016_bib19","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.4049\/jimmunol.172.8.4851","article-title":"The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports toll-like receptor 4 signaling in murine peritoneal macrophages","volume":"172","author":"Cao","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.25958","article-title":"PTEN-mediated Akt\/beta-catenin\/Foxo1 signaling regulates innate immune responses in mouse liver ischemia\/reperfusion injury","volume":"57","author":"Kamo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2014.05.016_bib21","doi-asserted-by":"crossref","first-page":"37041","DOI":"10.1074\/jbc.M305213200","article-title":"Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase\/AKT by saturated and polyunsaturated fatty acids","volume":"278","author":"Lee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.05.016_bib22","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.4049\/jimmunol.180.6.4218","article-title":"Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes\/macrophages","volume":"180","author":"Luyendyk","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.283.5400.393","article-title":"Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha","volume":"283","author":"Fruman","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.05.016_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.283.5400.390","article-title":"Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase","volume":"283","author":"Suzuki","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.05.016_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.20020805","article-title":"A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation","volume":"196","author":"Clayton","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.05.016_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.immuni.2006.08.015","article-title":"Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling","volume":"25","author":"Omori","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2014.05.016_bib27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20021101","article-title":"Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination","volume":"197","author":"Suzuki","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.05.016_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ni892","article-title":"Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function","volume":"4","author":"Anzelon","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib29","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.05.016_bib30","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of phosphatidylinositol 3\u2032-kinase\/AKT pathway in diffuse large B-cell lymphoma survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.05.016_bib31","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20091962","article-title":"Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases","volume":"207","author":"Miletic","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.05.016_bib32","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.177.8.5676","article-title":"Development of autoimmunity in IL-14alpha-transgenic mice","volume":"177","author":"Shen","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20021101","article-title":"Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination","volume":"197","author":"Suzuki","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.05.016_bib34","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.177.8.5676","article-title":"Development of autoimmunity in IL-14{alpha}-transgenic mice","volume":"177","author":"Shen","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/nar\/25.6.1317","article-title":"B lymphocyte-specific, Cre-mediated mutagenesis in mice","volume":"25","author":"Rickert","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2014.05.016_bib36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexcr.2014.05.016_bib37","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.ejca.2012.06.027","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K\/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies","volume":"48","author":"Mahadevan","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.05.016_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-07-0669","article-title":"A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity","volume":"68","author":"Garlich","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.05.016_bib39","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.4049\/jimmunol.166.7.4713","article-title":"Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin","volume":"166","author":"Monick","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib40","doi-asserted-by":"crossref","first-page":"16473","DOI":"10.1074\/jbc.M507373200","article-title":"Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52","volume":"281","author":"Gustin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.05.016_bib41","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.biocel.2006.03.023","article-title":"NFkappaB pathway: a good signaling paradigm and therapeutic target","volume":"38","author":"Tergaonkar","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib42","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/sj.onc.1209934","article-title":"IkappaB kinase complexes: gateways to NF-kappaB activation and transcription","volume":"25","author":"Scheidereit","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.05.016_bib43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI111754","article-title":"Human B lymphoma cell line producing B cell growth factor","volume":"75","author":"Ambrus","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2014.05.016_bib44","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.145.12.3949","article-title":"Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor","volume":"145","author":"Ambrus","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/bies.10306","article-title":"Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease","volume":"25","author":"Liou","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.yexcr.2014.05.016_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death","volume":"3","author":"Karin","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.yexcr.2014.05.016_bib48","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2014.05.016_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/10428194.2013.806800","article-title":"Inhibition of pan-class I PI3 kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B cell lymphoma","volume":"55","author":"Zang","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.yexcr.2014.05.016_bib50","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1182\/blood-2010-06-255067","article-title":"Novel therapeutic agents for B-cell lymphoma: developing rational combinations","volume":"117","author":"Reeder","year":"2011","journal-title":"Blood"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714002079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714002079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:43:45Z","timestamp":1689263025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482714002079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0014482714002079"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.05.016","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}